These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8773403)
1. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits. Reverte M; Rivas-Cabañero L Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403 [TBL] [Abstract][Full Text] [Related]
2. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines. Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220 [TBL] [Abstract][Full Text] [Related]
3. Effects of salbutamol and BRL 37344 on diastolic arterial blood pressure, plasma glucose and plasma lactate in rabbits. Reverte M; Moratinos J Fundam Clin Pharmacol; 1994; 8(5):417-24. PubMed ID: 7875635 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365 [TBL] [Abstract][Full Text] [Related]
5. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes. Fraeyman N; Van Ermen A; Van de Velde E; Vanscheeuwijck P Biochem Pharmacol; 1992 Dec; 44(12):2333-8. PubMed ID: 1361733 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of beta 2- and beta 3-adrenoceptors in plasma potassium control in conscious rabbits. Reverte M; García-Barrado MJ; Hernández-García FJ; Moratinos J J Auton Pharmacol; 1993 Jun; 13(3):227-36. PubMed ID: 8099912 [TBL] [Abstract][Full Text] [Related]
8. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057 [TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle. Liu YL; Cawthorne MA; Stock MJ Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636 [TBL] [Abstract][Full Text] [Related]
10. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors. Malinowska B; Schlicker E Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515 [TBL] [Abstract][Full Text] [Related]
11. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. Smith HJ; Halliday SE; Earl DC; Stribling D J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820 [TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor subtype expression and function in rat white adipocytes. Germack R; Starzec AB; Vassy R; Perret GY Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110 [TBL] [Abstract][Full Text] [Related]
13. Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes. Hollenga C; Zaagsma J Br J Pharmacol; 1989 Dec; 98(4):1420-4. PubMed ID: 2575416 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery. Leblais V; Pourageaud F; Ivorra MD; Marthan R; Muller B Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):535-9. PubMed ID: 16012871 [TBL] [Abstract][Full Text] [Related]
15. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. John GW; Doxey JC; Walter DS; Reid JL Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400 [TBL] [Abstract][Full Text] [Related]
16. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Tamaoki J; Tagaya E; Isono K; Nagai A Biochem Biophys Res Commun; 1998 Jul; 248(3):722-7. PubMed ID: 9703994 [TBL] [Abstract][Full Text] [Related]
17. Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice. Yoshida T; Hiraoka N; Kondo M Endocrinol Jpn; 1991 Dec; 38(6):641-6. PubMed ID: 1688048 [TBL] [Abstract][Full Text] [Related]
18. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs. Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598 [TBL] [Abstract][Full Text] [Related]
19. Effects of two beta3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart. Kozlovski VI; Chlopicki S; Gryglewski RJ J Cardiovasc Pharmacol; 2003 May; 41(5):706-13. PubMed ID: 12717100 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation. Liu YL; Stock MJ Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]